Gemcitabine sensitizes pancreatic cancer cells to the CTLs antitumor response induced by BCG-stimulated dendritic cells via a Fas-dependent pathway

Cancer Statistics, 2009

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2009 · 9.7K citations · Full text

Epidemiology Of Cancer, Pathology, Cancer Registration +18

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.8K citations

Proliferating dendritic cell progenitors in human blood.

Nikolaus Romani, Susanne Grüner, D Brang et al. · The Journal of Experimental Medicine · 1994 · 1.9K citations · Full text

Dc Aggregates, Small Dc Aggregates, Immunology +16

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

Noëlia Casares, Marie O. Péquignot, Antoine Tesnière et al. · The Journal of Experimental Medicine · 2005 · 1.4K citations · Full text

Immunology, Immunoediting, Cell Death +16

Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity

Eiji Suzuki, Veena Kapoor, Arminder S. Jassar et al. · Clinical Cancer Research · 2005 · 1K citations